Acadian Asset Management LLC Raises Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Acadian Asset Management LLC grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 108.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 7,021 shares of the company’s stock after acquiring an additional 3,649 shares during the period. Acadian Asset Management LLC’s holdings in HCA Healthcare were worth $2,253,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the stock. CreativeOne Wealth LLC purchased a new stake in shares of HCA Healthcare in the 1st quarter valued at $231,000. New Mexico Educational Retirement Board lifted its position in shares of HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares in the last quarter. Sanders Capital LLC increased its stake in HCA Healthcare by 4.2% during the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares during the period. KBC Group NV boosted its position in HCA Healthcare by 60.6% in the 4th quarter. KBC Group NV now owns 365,984 shares of the company’s stock valued at $99,065,000 after buying an additional 138,146 shares during the period. Finally, Kingswood Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at $566,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on HCA shares. Morgan Stanley initiated coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Oppenheimer increased their target price on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. UBS Group upped their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Finally, Robert W. Baird assumed coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The disclosure for this sale can be found here. Insiders sold a total of 17,202 shares of company stock valued at $6,407,273 in the last ninety days. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA opened at $394.68 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock’s 50 day moving average is $362.19 and its two-hundred day moving average is $338.06. The firm has a market capitalization of $101.86 billion, a PE ratio of 19.67, a P/E/G ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $403.05.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $4.29 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 22.46 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s payout ratio is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.